Top Abstract Purchase Related
Home
>
Node
>
Subnode

Influences of cardiopulmonary bypass in elderly patients

Tabayashi, K.

Kyobu Geka. Japanese Journal of Thoracic Surgery 58(8 Suppl): 632-635

2005

ISSN/ISBN: 0021-5252
PMID: 16097609
Document Number: 591172
Organ hypofunction by aging exaggerate damages, which are caused by cardiopulmonary bypass. The main cause of organ dysfunction after cardiopulmonary bypass is systemic inflammatory response, which is induced by continuous interaction of blood with unphysiologic surfaces, shear stress to blood cells, and incorporation of abnormal substances. To reduce the postoperative complications after cardiovascular surgery in elderly patients, intensive and careful control of cardiopulmonary bypass and several kinds of anti-inflammatory treatment are important.

Document emailed within 1 workday
Secure & encrypted payments

Naumenko, S.E. 2008: The effect of surgery with cardiopulmonary bypass on oxygen transport in elderly patients with ischemic heart disease Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 94(1): 53-61
Murphy, D.A.; Armour, J.A. 1992: Influences of cardiopulmonary bypass, temperature, cardioplegia, and topical hypothermia on cardiac innervation Journal of Thoracic and Cardiovascular Surgery 103(6): 1192-1199
Gotou, K.; Kimura, F.; Kimura, N.; Hashimoto, Y.; Wakayama, S. 1997: The anesthetic management of patients in chronic renal failure for coronary artery bypass surgery without cardiopulmonary bypass Masui. Japanese Journal of Anesthesiology 46(12): 1609-1614
Go, R.; Mori, K.; Abe, T.; Kohyama, A.; Kataoka, Y.; Bandoh, M. 1997: Coronary artery bypass grafting on the beating heart in patients with severe cardiac dysfunction; on the necessity of cardiopulmonary bypass Masui. Japanese Journal of Anesthesiology 46(9): 1209-1214
Faulí, A.; Gomar, C.; Campistol, J.M.; Alvarez, L.; Manig, A.M.; Matute, P. 2005: Kidney-specific proteins in patients receiving aprotinin at high- and low-dose regimens during coronary artery bypass graft with cardiopulmonary bypass European Journal of Anaesthesiology 22(9): 666-671
Knöbl, P.N.; Zilla, P.; Fasol, R.; Müller, M.M.; Vukovich, T.C. 1987: The protein C system in patients undergoing cardiopulmonary bypass Journal of Thoracic and Cardiovascular Surgery 94(4): 600-605
Bubenik, O.; Meakins, J.L. 1976: Neutrophil chemotaxis in surgical patients: effect of cardiopulmonary bypass Surgical Forum 27(62): 267-269
Barta, E.; Kuzela, L.; Kvetnansky, R.; Siska, K.; Babusikova, F.; Torda, M.; Cornak, V.; Horecky, J. 1976: Activity of sympathetic nerves in heart during cardiopulmonary bypass in patients Journal of Cardiovascular Surgery 17(2): 174-177
Frering, B.; Philip, I.; Dehoux, M.; Rolland, C.; Langlois, J.M.; Desmonts, J.M. 1994: Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass Journal of Thoracic and Cardiovascular Surgery 108(4): 636-641
Manning, S.H.; Angaran, D.M.; Arom, K.V.; Lindsay, W.G.; Northrup, W.F.; Nicoloff, D.M. 1982: Intermittent intravenous potassium therapy in cardiopulmonary bypass patients Clinical Pharmacy 1(3): 234-238
Mishra, Y.; Mehta, Y.; Kohli, V.M.; Kohli, V.; Mairal, M.; Mishra, A.; Bapna, R.K.; Trehan, N. 1997: Coronary artery bypass surgery without cardiopulmonary bypass: short- and mid-term results Indian Heart Journal 49(5): 511-517
Okada, M.; Tatoulis, J. 2002: Coronary artery bypass grafting without cardiopulmonary bypass: MIDCAB and OPCAB Kyobu Geka. Japanese Journal of Thoracic Surgery 55(6): 483-485
Sakai, H.; Iwatani, Y.; Katayama, Y.; Tajima, K.; Yamamoto, F.; Fujita, A. 1989: The changes in immunoglobulin, complements and serum protein in patients using different types of cardiopulmonary bypass Rinsho Byori. Japanese Journal of Clinical Pathology 37(5): 522-526
Scheinman, M.M.; Sullivan, R.W.; Hutchinson, J.C.; Hyatt, K.H. 1971: Clinical significance of changes in serum magnesium in patients undergoing cardiopulmonary bypass Journal of Thoracic and Cardiovascular Surgery 61(1): 135-140
Inoue, K. 2004: Effect of respiratory care on pulmonary function in patients after cardiopulmonary bypass Masui. Japanese Journal of Anesthesiology 53(6): 622-628
Xu, L.; He, Z.; Shen, J. 1998: Effects of aprotinin on activated coagulation time in the patients during cardiopulmonary bypass Hunan Yi Ke da Xue Xue Bao 23(2): 215-216
D'Ancona, G.; Karamanoukian, H.; Ricci, M.; Salerno, T.; Lajos, T.; Bergsland, J. 2001: Reoperative coronary artery bypass grafting with and without cardiopulmonary bypass: determinants of perioperative morbidity and mortality Heart Surgery Forum 4(2): 152-158 Dicussion: 158-159
Wu, M.; Chen, R.-k.; Cremer, J. 2004: Application of dynamic bubble trap in coronary artery bypass with cardiopulmonary bypass: an initial study Zhonghua Yi Xue Za Zhi 84(23): 1986-1989
Iqbal, J.; Ghaffar, A.; Shahbaz, A.; Abid, A.R. 2014: Stroke after coronary artery bypass surgery with and without cardiopulmonary bypass Journal of Ayub Medical College Abbottabad: Jamc 26(2): 123-128
Lu, H.; Du Buit, C.; Soria, J.; Touchot, B.; Chollet, B.; Commin, P.L.; Conseiller, C.; Echter, E.; Soria, C. 1994: Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy Thrombosis and Haemostasis 72(3): 438-443